Sort   by:  
 Page size 
UnknownMetformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.

Aims

Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on prognosis in patients with type 2 diabetes hospitalised for COVID-19.

Methods

CORONADO is a nationwide observational study that included patients with diabetes hosp...
S-EPMC7832745 | biostudies-literature
UnknownProminent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes.
Lifestyle factors influence both gut microbiome composition and host metabolism, yet their combined and mediating effects on host phenotypes remain poorly characterized in cardiometabolic populations. In 1,643 participants from the MetaCardis study, we developed a composite lifestyle score (QASD: di...
S-EPMC12795280 | biostudies-literature
UnknownType 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study.
Not available
S-EPMC7576421 | biostudies-literature
UnknownThe association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).

Background

It is not clear whether pre-existing macrovascular complications (ischemic heart disease, stroke or peripheral artery disease) are associated with health outcomes in people with diabetes mellitus hospitalized for COVID-19.

Methods

We conducted cohort studies of adults with ...
S-EPMC9580453 | biostudies-literature
Sort   by:  
 Page size